Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has closed a GBP£2 million oversubscribed seed ...

In this review, Peter tests the facelifted Renault Austral, a practical full-hybrid family SUV that combines efficient ...

Healome Therapeutics, a University of Birmingham spinout, closed an oversubscribed £2 million seed financing round led by ...

KTC, a leading brand in professional display technology, today announced the continued expansion of its all-scenario gaming ...

Claritev Corporation (NYSE: CTEV), a technology, data, and insights company focused on making healthcare more affordable and transparent, today announced it has been recognized as a Leader in the ...

QKS Group announced today that it has recognized NETSCOUT as a Leader in the SPARK Matrix™: Network Observability, 2026.

QKS Group announced today that it has named Kubermatic as a leader in the SPARK Matrix ™: Edge Kubernetes Platforms, Q3 2026.

The spin-out’s proprietary technology combines drug retention, lubrication and protection, for a range of diseases affecting the surface of the eye.

Quantifind, the leader in AI-native Risk Intelligence for financial crime and national security, today announced it has been ...